Clinical trial
A Multi-Centre, Prospective Study to Obtain Survival and Clinical Outcome Data on the Zimmer Hip Resurfacing System Utilising the Metasul Monoblock Component™ Cup in a Hip Resurfacing Application With the Durom® Hip Resurfacing Femoral Component.
NCT03681639 is registered in ClinicalTrials.gov with Zimmer Biomet as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Centre, Prospective Study to Obtain Survival and Clinical Outcome Data on the Zimmer Hip Resurfacing System Utilising the Metasul Monoblock Component™ Cup in a Hip Resurfacing Application With the Durom® Hip Resurfacing Femoral Component.
- Lead sponsor
- Zimmer Biomet
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 1, 2009
- Completion date
- May 22, 2023
- Enrollment
- 45 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
avascular necrosis of hip, inflammatory arthritis, osteoarthritis, hip, post-traumatic; arthrosis, rheumatoid arthritis